Vaccines against human respiratory syncytial virus in clinical trials, where are we now?
(2019) Iebe Rossey (UGent), Xavier Saelens (UGent)
Clinical potential of prefusion RSV F-specific antibodies
(2018) Iebe Rossey (UGent), Jason S McLellan, Xavier Saelens (UGent), Bert Schepens (UGent)
Potent single-domain antibodies that arrest respiratory syncytial virus fusion protein in its prefusion state
(2017) Iebe Rossey (UGent), Morgan SA Gilman, Stephanie C Kabeche, Koen Sedeyn (UGent), Daniel Wrapp, Masaru Kanekiyo, Man Chen, Vicente Mas, Jan Spitaels (UGent), José A Melero, Barney S Graham, Bert Schepens (UGent), Jason S McLellan, Xavier Saelens (UGent)
Personal data from this phone book may only be used for communication with individuals in the context of the mission of Ghent University.